Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer (Q24632187)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q42532150)
(Q90227155)
(Q6137574)
(Q97434516)
(P304) 1099-105
(P407) (Q1860)
(P433) 7
(P478) 28
(P577) Monday, March 1, 2010
(P921) (Q42824440)
(Q1427096)
(Q1436668)
(Q181257)
(P1433) (Q400292)
(P1476) "Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer" (language: en)
(P2093) Thomas J Schuetz
Brent A Blumenstein
L Michael Glode
David L Bilhartz
Michael Wyand
Kelledy Manson
Dennis L Panicali
Reiner Laus
Philip M Arlen
Wayne R Godfrey
(P2860) (Q25255692)
(Q33703387)
(Q36868126)
(Q34543188)
(Q36251078)
(Q36065372)
(Q34150448)
(Q40621333)
(Q33767866)
(Q41682845)
(Q46817220)
(Q51899945)
(Q44770464)
(Q45197611)
(Q47414992)
(Q44381567)
(Q73877528)
(Q60368025)
(Q73229810)
(Q78386134)
other details
description scientific article

External Links